Medium-to-Long-Term Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine: A Retrospective Cohort Study.
Bianchi FP, Stefanizzi P, Germinario CA, Migliore G, Vimercati L, Martinelli A, Lobifaro A, Diella G, Larocca AMV, Control Room Working Group, Tafuri S.
Bianchi FP, et al. Among authors: martinelli a.
Vaccines (Basel). 2022 Mar 10;10(3):417. doi: 10.3390/vaccines10030417.
Vaccines (Basel). 2022.
PMID: 35335049
Free PMC article.